Background To study the epidemiology of childhood-onset type 1 insulin-dependent diabetes in Europe, the EURODIAB collaborative group established in 1988 prospective geographically-defined registers of new cases diagnosed under 15 years of age. This report is based on 16 362 cases registered during the period 1989-94 by 44 centres representing most European countries and Israel and covering a population of about 28 million children.
Introduction
Type 1 insulin-dependent diabetes is generally believed to be due to an immune destruction of pancreatic ␤ cells in genetically susceptible individuals exposed to environmental risk factors. There has been a rapid increase in the incidence of type 1 diabetes in many European countries in the past few decades. [1] [2] [3] [4] This increase, in conjunction with the lack of complete concordance in monozygotic twin pairs, [5] [6] [7] points to the importance of environmental factors.
Useful clues about these environmental factors may be obtained by studying geographical variation in incidence in relation to the characteristics of different countries. Fundamental to such analyses are high-quality incidence data uniformly collected via a standard protocol from population-based registers. We have previously reported data for the years 1989-90 from 26 registries in the EURODIAB Study Group, and have established that there is a wide range of incidence rates within Europe. 8 The network has since expanded to include 44 registries, with representation from most European countries and Israel. Incidence data for the 6-year period 1989-94 are presented in this paper.
Differences in the trends in incidence between countries or age-groups may also provide important clues about environmental factors. Some recent reports suggest a higher rate of increase among children under 5 years of age compared with the age groups 5-9 and 10-14 years, 9, 10 which suggests that the environmental factors responsible for the increase may operate early in life. We address this issue in our analysis of the EURODIAB registry data.
Methods
The establishment of the EURODIAB collaborative group of childhood diabetes registers has been described in detail. 8, 11 Briefly, in 1988, prospective registers of new cases of insulindependent type 1 diabetes mellitus among children aged under 15 years were established in 26 geographically-defined centres in Europe and Israel. Type 1 diabetes was defined on the basis of a clinical diagnosis of idiopathic diabetes made by a physician. Cases secondary to other conditions (having cystic fibrosis or high-dose steroid treatment) were excluded. Date of onset was taken as the date of the first insulin injection. Anonymous data were submitted to a central coordinating office in Odense, Denmark, for data processing and analysis.
Other centres whose registries met the same quality criteria have since joined the group, which now comprises 44 centres. Many of the new participants are from central and eastern Europe, and most European countries are now represented. For the analysis of trends the 40 centres with data for all 6 years in the study period were grouped into countries.
Capture-recapture methodology, 12 which assumes the availability of independent primary and secondary sources of ascertainment, was used when possible to estimate the completeless of registration. In most centres the primary source of ascertainment was through hospital records or notifications by paediatricians and family doctors. Secondary sources varied, being dependent on local circumstances, but included social insurance schemes, diabetes associations, and prescription data.
Annual estimates of the population resident in each centre's geographically-defined area were used as denominators for the Variation and trends in incidence of childhood diabetes in Europe EURODIAB ACE Study Group* calculation of rates. Age/sex standardised incidence rates were obtained by the direct method with a standard population consisting of equal numbers of children in each of six subgroups defined by age group (0-4, 5-9, and 10-14 years) and sex.
Poisson-regression models were used to study differences in incidence rate between countries and to investigate the trends in incidence rate. Models with terms for sex, age group (0-4, 5-9, and 10-14 years), country, and calendar year were fitted. These models take account of possible differences in age/sex structure in each country's population and permit testing for any linear trend in incidence rate within a country. Further models incorporating interaction terms were used to test for differences in the linear trends between countries, between sexes, and between age groups. Likelihood-ratio 2 tests were used to compare the fit of nested models and to provide a test of significance for the last term added to the model. Models were fitted by the SAS GENMOD procedure. (SAS system for Windows, release 6.12, SAS Institute Inc, North Carolina, USA.) Table 1 summarises registration for each centre-the number of cases, the standardised average annual incidence rate, and the estimated completeness of ascertainment. Among the 40 centres validating ascertainment, all but four achieved completeness of ascertainment of over 95%. The estimates for some centres exclude the early years of the study period, but estimates for the years 1989-90 have already been published. 8 The standardised rates varied from 3·2 cases per 100 000 per year in the Former Yugoslav Republic of Macedonia to 40·2 cases per 100 000 in the two regions of Finland. Incidence rates were high in northern and north-western Europe and low in central, southern, and eastern Europe (figure 1). However, Sardinia was a notable exception to this pattern, with a much higher rate than any neighbouring region.
Results
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Data for each of the 6 years of the study period were available for all but four of the centres (GermanyDüsseldorf, Israel, Poland-Bialystok, and Switzerland).
Poisson-regression models were fitted separately for each country, after data for the centres within each country were pooled. Sardinia, however, was retained as a centre on its own because the incidence there was much higher than for other Italian centres. There was evidence of a significant linear trend in nine of the 29 analyses, all but one showing an increase in incidence rate (table 2) . For one country there was evidence of departure from linear trend (p=0·04), but this was no more than might be expected by chance and the annual rates for the country in question showed no consistent pattern. Some central and eastern European countries had rates that increased rapidly (table 2) . The results of fitting Poisson-regression models to the data from all countries simultaneously are summarised in table 3. Preliminary model fitting confirmed that there were significant differences in incidence rate between countries and suggested that both sex and age effects differed from country to country. A base model incorporating terms for age, sex, and country was therefore fitted to allow for differences in age/sex specific rates from country to country. Models that specified different patterns of linear trend were then obtained by adding terms to the base model. The test of the overall trend in incidence rate shown in the second line of table 3 is highly significant, with a risk ratio estimate of 1·034 (95% CI 1·025-1·044), which indicates on average a 3·4% (2·5-4·4%) increase in incidence per year. Table 3 indicates a significant difference in the trends between countries (line 3) and a difference in the trends between age groups (line 4) with no evidence of a difference in trends between boys and girls (line 5) and no evidence that the difference in trends between age-groups varied between boys and girls (line 6). The age-specific annual rates pooled across countries are displayed for boys and girls in figure 2 with a logarithmic vertical scale. Estimates of the rates of increase in the three age groups pooled over countries and sexes were 6·3% (4·1-8·5%) for children aged 0-4 years, 3·1% (1·5-4·8%) for 5-9 years, and 2·4% (1·0-3·8%) for 10-14 years, which shows that in relative terms the highest rates of increase occurred in the youngest age group.
Discussion
This multicentre study shows a greater than 10-fold range in incidence rate of childhood diabetes in Europe. Such variation seems unlikely to be explained by genetic differences, since Europeans (except for some outlying populations) are more homogeneous compared with the indigenous populations of other continents. 13 Although the independence of primary and secondary sources of ascertainment cannot easily be verified our assessment of completeness is more thorough than in most previous studies of international variations in incidence, and underascertainment is unlikely to be a major factor in explaining the incidence variation described here.
The rapid increase in incidence is not readily explained by shifts in the frequency of susceptibility genes, and change in environmental factors is a more plausible explanation. A homogeneous pattern of increasing incidence across age groups would suggest that similar environmental exposures operate in each age group. However, our observation of a greater relative increase in incidence in those under 5 years supports the importance of exposures operating early in life. 14, 15 The nature of these exposures is not yet clear, but increased perinatal infections 16, 17 or a rapid growth rate in early life 18, 19 could be contributing. 6 years is too short a period to investigate age-group differences in incidence trends Account has been taken of changes in age/sex structure of population. *Base model=constant+age+sex+ageϫsex+country+ageϫcountry+sexϫcountry+ageϫsexϫcountry. Age: terms for age groups 0-4, 5-9, and 10-14 years; Sex: terms for sex; Country: terms for country; Year: terms for linear trend across the 6 years; Ageϫsex: terms for the interaction between age-group and sex. within each centre. Our modelling compared age-group differences in incidence trends pooled over centres instead, which took account of the different trends in the various centres. It is tempting to link the rapid increase in incidence rates in some central and eastern European countries with recent political changes. However, the long prediabetic phase thought to be involved in the pathogenesis of this disease 20 suggests that the factors responsible for these rapid increases may have operated earlier. It will be important to continue monitoring the incidence rate trends in these countries and to compare them with those in Romania and the republics of former Yugoslavia where increases in incidence rate are not yet apparent.
